Patents by Inventor Russell Bey

Russell Bey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunological compositions containing attenuated
    Patent number: 10098941
    Abstract: This disclosure provides attenuated Histophilus somni strains, compositions comprising same, and methods of production and use thereof. The attenuated strains may express lower or no levels of various virulence-associated genes, relative to the corresponding pathogenic bacteria Advantageously, the attenuated Histophilus somni strains may be administered orally, intranasally, intra-tracheally, or subcutaneously.
    Type: Grant
    Filed: January 30, 2017
    Date of Patent: October 16, 2018
    Assignee: MERIAL INC.
    Inventors: Tammy (Kolander) Bremer, Paulraj Lawrence, Russell Bey
  • Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV)
    Patent number: 9713639
    Abstract: The present invention encompasses porcine epidemic diarrhea virus (PEDV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing PEDV antigens. The invention also encompasses recombinant vectors encoding and expressing PEDV antigens, epitopes or immunogens which can be used to protect porcine animals against PEDV.
    Type: Grant
    Filed: May 19, 2015
    Date of Patent: July 25, 2017
    Assignee: MERIAL, INC.
    Inventors: Paulraj Lawrence, Russell Bey
  • Immunological Compositions Containing Attenuated Histophilus somni
    Publication number: 20170157232
    Abstract: This disclosure provides attenuated Histophilus somni strains, compositions comprising same, and methods of production and use thereof. The attenuated strains may express lower or no levels of various virulence-associated genes, relative to the corresponding pathogenic bacteria Advantageously, the attenuated Histophilus somni strains may be administered orally, intranasally, intra-tracheally, or subcutaneously.
    Type: Application
    Filed: January 30, 2017
    Publication date: June 8, 2017
    Applicant: MERIAL, INC.
    Inventors: Tammy (Kolander) Bremer, Paulraj Lawrence, Russell Bey
  • Immunological compositions containing attenuated
    Patent number: 9592283
    Abstract: This disclosure provides attenuated Histophilus somni strains, compositions comprising same, and methods of production and use thereof. The attenuated strains may express lower or no levels of various virulence-associated genes, relative to the corresponding pathogenic bacteria Advantageously, the attenuated Histophilus somni strains may be administered orally, intranasally, intra-tracheally, or subcutaneously.
    Type: Grant
    Filed: March 25, 2015
    Date of Patent: March 14, 2017
    Assignee: MERIAL, INC.
    Inventors: Tammy Kolander, Paulraj Lawrence, Russell Bey
  • Recombinant Spike Protein Subunit Based Vaccine for Porcine Epidemic Diarrhea Virus (PEDV)
    Publication number: 20150328307
    Abstract: The present invention encompasses porcine epidemic diarrhea virus (PEDV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing PEDV antigens. The invention also encompasses recombinant vectors encoding and expressing PEDV antigens, epitopes or immunogens which can be used to protect porcine animals against PEDV.
    Type: Application
    Filed: May 19, 2015
    Publication date: November 19, 2015
    Applicant: MERIAL, INC.
    Inventors: Paulraj Lawrence, Russell Bey
  • Immunological Compositions Containing Attenuated Histophilus somni
    Publication number: 20150273045
    Abstract: This disclosure provides attenuated Histophilus somni strains, compositions comprising same, and methods of production and use thereof. The attenuated strains may express lower or no levels of various virulence-associated genes, relative to the corresponding pathogenic bacteria Advantageously, the attenuated Histophilus somni strains may be administered orally, intranasally, intra-tracheally, or subcutaneously.
    Type: Application
    Filed: March 25, 2015
    Publication date: October 1, 2015
    Applicant: MERIAL, INC.
    Inventors: Tammy Kolander, Paulraj Lawrence, Russell Bey